Science Corporation’s vision-restoring chip wins EU approval
Science Corporation, a start-up developing novel brain-computer interfaces (BCI), won approval from Europe’s medical device regulator to begin selling a device that restores vision lost from age-related macular degeneration.
The company said the device, called PRIMA, also received a designation from the US Food and Drug Administration that is the first step toward an expedited regulatory review, which could see the device used to treat two rare kinds of blindness.
Millions of people around the world suffer from age-related macular degeneration, which destroys the light-sensitive cells at the back of the eyes, making it difficult to read and recognize faces.
To use the device, patients suffering from this loss of vision undergo an hour-long outpatient procedure that plants a small chip in back of their eye. Then, they wear camera-equipped glasses that transmit a view of the world to the chip. Max Hodak, Science Corporation’s founder and CEO, says the...
Copyright of this story solely belongs to techcrunch.com. To see the full text click HERE
